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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYPrimordial germ cells (PGCs) are fate restricted to differentiate into gametes in vivo. However, when removed from their embryonic
niche, PGCs undergo reversion to pluripotent embryonic germ cells (EGCs) in vitro. One of the major differences between EGCs and
embryonic stem cells (ESCs) is variable methylation at imprinting control centers (ICCs), a phenomenon that is poorly understood.
Here we show that reverting PGCs to EGCs involved stable ICC methylation erasure at Snrpn, Igf2r, and Kcnqot1. In contrast, the H19/
Igf2 ICC undergoes erasure followed by de novo re-methylation. PGCs differentiated in vitro from ESCs completed Snrpn ICC erasure.
However, the hypomethylated state is highly unstable.We also discovered that when theH19/Igf2 ICCwas abnormally hypermethylated
in ESCs, this is not erased in PGCs differentiated from ESCs. Therefore, launching PGC differentiation from ESC lines with appropriately
methylated ICCs is critical to the generation of germline cells that recapitulate endogenous ICC erasure.INTRODUCTION
Nuclear reprogramming of somatic cells using genetic
modification and overexpression of pluripotent transcrip-
tion factors is essential for creating induced pluripotent
stem cells (iPSCs) in vitro (Takahashi and Yamanaka,
2006). An alternate approach that does not entail genetic
modification involves primordial germ cells (PGCs) from
the embryo, followedby culture-induced reversion into em-
bryonic germ cell (EGC) lines. Both EGCs and iPSCs tran-
scriptionally resemble undifferentiated embryonic stem
cells (ESCs) in vitro, and, similar to ESCs, EGCs derived by
PGC reversion in vitro have the capacity to contribute to
chimeras with germline transmission (Labosky et al.,
1994; Leitch et al., 2013b; Matsui et al., 1992; Resnick
et al., 1992; Sharova et al., 2007; Stewart et al., 1994; Takaha-
shi and Yamanaka, 2006). Despite these similarities, one of
themajor epigenetic differenceswithEGCs and iPSCs is var-
iable methylation at imprinting control centers (ICCs).
Competency for PGC reversion to EGCs in the mouse
embryo is found during a 6-day window starting from the
time of PGC specification at embryonic day 7.5 (E7.5)
through E13.5 after PGCs have settled in the genital ridge
(Labosky et al., 1994; Leitch et al., 2013b, 2013c; Matsui
et al., 1992; Resnick et al., 1992; Shim et al., 2008; Stewart
et al., 1994; Tada et al., 1998). During this time, the germ-
line undergoes a unique two-stage DNA demethylation
event. In the first stage, which is completed soon after spec-
ification (at around E8.0), cytosinemethylation is removed
genome-wide from more than 50% of cytosines in a CGStem Cellsequence context (Seisenberger et al., 2012).Methylated re-
gions that are protected in the first stage include ICCs,
some gonadal stage germline genes, particularly those
involved in meiosis, as well as endogenous retroviruses
(Guibert et al., 2012; Hajkova et al., 2002; Seisenberger
et al., 2012; Vincent et al., 2013). In the second stage,
which extends from E9.5 to E13.5, cytosine methylation
in PGCs is removed in a time and locus-specific manner,
with E13.5 PGCs considered the most hypomethylated
germline epigenetic ground state. This includes removing
(also referred to as erasing) methylation from ICCs in prep-
aration for establishing newmethylatedmarks onDNA in a
sex-specific manner (Guibert et al., 2012; Hajkova et al.,
2002; Kagiwada et al., 2013; Seisenberger et al., 2012).
Cytosine methylation in EGC lines has been studied
extensively and the prevailing hypothesis is that ICCs are
generally hypomethylated. However, close analysis reveals
that ICC cytosine methylation is extremely variable, not
only between lines but also between ICC sites within a
given line (Labosky et al., 1994; Leitch et al., 2013a; McLa-
ren and Durcova-Hills, 2001; Shim et al., 2008; Shovlin
et al., 2008; Tada et al., 1998). This variability has led to
threemajor hypotheses for cytosinemethylation dynamics
during PGC reversion to EGCs. The first hypothesis is that
EGC lines reflect the epigenetic status of the PGCs in the
embryo from which they were originally derived. The sec-
ond hypothesis is that PGCs undergo incomplete cytosine
methylation erasure, and thus the variable status in estab-
lished EGC lines is due to heterogeneously terminated de-
methylation. The third hypothesis is that PGCs undergoReports j Vol. 5 j 337–349 j September 8, 2015 j ª2015 The Authors 337
demethylation as well as de novo methylation during the
process of reverting from PGCs to EGCs.
In order to support or reject the hypotheses above, a
critical analysis of PGCs immediately before, during,
and after the process of reversion into EGCs is required.
Understanding ICC methylation erasure and/or establish-
ment provides a powerful opportunity to uncover basic
principles of cytosine demethylation, stabilization of the
hypomethylated state, and establishment of cytosine
methylation in a locus-specific manner.RESULTS
Reversion of PGCs to EGCs Is Initially Associated
with Germline Differentiation
In order to understand the initial events in EGC derivation,
we first cultured E9.5 PGCs for 4 days under EGC deriva-
tion conditions, and we examined the timing of pioneer-
ing colony formation (Figure 1). The EGC derivation
medium was based on a formulation for short-term main-
tenance of cultured E11.5 PGCs (Farini et al., 2005), and it
contained fetal bovine serum (FBS) plus seven additional
components as follows: fibroblast growth factor 2 (FGF2);
chemokine (C-X-C Motif) ligand 12 (CXCL12), also called
SDF1; stem cell factor (SCF), also called KIT-ligand; bone
morphogenetic protein 4 (BMP4); leukemia inhibitory
factor (LIF); forskolin; and N-acetyl cysteine (NAC). There-
fore, for simplicity, the medium is referred to as 7-factor
(7F). PGCs were sorted from the dorsal region of E9.5
embryos by crossing CD1 females to Oct4-IRES-Gfp males
(Figure 1A). Bisulfite (BS) treatment, of DNA isolated
from GFP-positive PGCs and GFP-negative somatic cells,
followed by PCR (BS-PCR) and sequencing of clones re-
vealed that the Snrpn and H19/Igf2 ICCs contained both
methylated and unmethylated alleles, similar to previous
reports (Figure 1B; Vincent et al., 2011). For EGC deriva-
tion, the GFP-positive PGCs were collected by sorting
and then cultured on an acellular polyethylene tere-
phthalate (PET) membrane to allow germ cell attachment
without a protein substrate (Figure 1C). Sorted PGCs
attached to the membrane within the first day of 7F
culture, and most PGCs exhibited round (arrowhead)
morphology (Figure 1C). On day 2, some PGCs acquired
an elongated shape (arrows). These round and elongated
PGCs remained as single cells on day 3, with small pioneer-
ing colonies first appearing between day 3 and day 4
(Figure 1C).
To determine whether colony formation was associated
with PGC differentiation, we evaluated expression of the
germline-specific protein called mouse vasa homolog
(MVH). This protein is negative in PGCs at E9.5 and first
becomes detectable in the germline from E10.5 to E11.5338 Stem Cell Reports j Vol. 5 j 337–349 j September 8, 2015 j ª2015 The A(Toyooka et al., 2000). Immunofluorescence staining of
embryos at E9.5 for OCT4 and MVH revealed that OCT4-
positive (red) PGCs were negative for MVH (green) (Fig-
ure 1D). Adult testis containing MVH-positive germ cells
was used as a positive control (Figure 1E). On the fourth
day of culture in 7Fmedium, immunofluorescence staining
with the anti-MVH antibody revealed that a large fraction
of cultured PGCs expressed MVH protein in the cytoplasm
(Figure 1F). In contrast, non-specific background signal was
detectedwhen using an isotype-matched primary antibody
as a negative control (Figure 1G and quantified in Fig-
ure 1H). To confirm that cultured PGCs are OCT4 positive
and originated from the Oct4-IRES-Gfp-sorted germline
cells, we performed live imaging on day 4 and showed
that 98% of PGCs expressed GFP (Figure 1I). This result in-
dicates that the majority of E9.5 PGCs differentiate into
MVH-positive germline cells within the first 4 days of 7F
culture ex vivo, and that pioneering colony formation oc-
curs between day 3 and day 4.
To determine whether 7F-cultured PGCs are capable of
generating EGC lines, we trypsinized the cultured PGCs,
and plated the cells on mouse embryonic fibroblasts
(MEFs) in mouse ESC media containing serum plus LIF.
Within the first 4 days of plating, dome-shaped colonies
of GFP-positive cells emerged, which were passaged as sin-
gle cells in trypsin to generate self-renewing colonies of
GFP-positive EGC lines (Figure 2A). To evaluate germline
identity, we examined MVH protein expression by immu-
nofluorescence and discovered that MVH protein was no
longer detectable (Figure 2B). As a positive control, we
transiently transfected EGCs with a plasmid constitutively
expressing the open reading frame of VASA, and we per-
formed immunofluorescence with the anti-MVH antibody
where signal could be detected in transfected cells (Fig-
ure 2C). Cell surface immunophenotyping demonstrated
that the majority of OCT4-positive cells were also positive
for the mouse pluripotent stem cell marker stage-specific
embryonic antigen 1 (SSEA1) (Figure 2D). We quantified
double-positive cells in three independently derived EGC
lines, and we found that, in all three lines, the majority
of Oct4-gfp cells are also SSEA1 positive (Figure 2E). We
also performed teratoma analysis to examine pluripotency
and discovered that the EGCs derived from 7F-cultured
PGCswere capable of teratoma formation, with tumors dis-
playing evidence of ectoderm, mesoderm, and endoderm
(Figure 2F).
Differential ICC Methylation in EGC Lines
To evaluate DNA methylation, we chose three indepen-
dently derived EGC lines and performed BS-PCR followed
by cloning and sequencing for Snrpn and H19/Igf2 ICCs
(Figure 3A). In order to prevent contamination with feeder
cells, we used fluorescence-activated cell sorting (FACS)uthors
Figure 1. PGCs Cultured Ex Vivo Generate Colonies within 4 Days
(A) FACS plot showing gate for isolating GFP+ PGCs at E9.5. SSC, side scatter.
(B) BS-PCR followed by cloning and sequencing for Snrpn and H19/Igf2 ICCs in sorted GFP+ PGCs and GFP somatic cells (Soma) at E9.5.
(C) E9.5 PGCs cultured in 7F for 4 days. Arrowheads, round PGCs; arrows, elongated PGCs; circled area, a pioneering PGC colony.
(D) Whole-mount stain of E9.5 embryo for MVH (green) and OCT4 (red).
(E) Adult testis containing MVH+ OCT4 germ cells. Arrows point to a representative MVH+ OCT4 cell.
(F) Immunofluorescence for MVH on day 4 of culture in 7F medium. Arrows indicate cytoplasmic staining.
(G) Isotype (IgG) control. Arrows indicate background signal.
(H) Quantification of MVH+ cells on day 4 of culture in 7F medium (n = 1 biological replicate with 19 cells counted in six fields).
(I) Live imaging of GFP+ E9.5 PGCs on day 4 of culture in 7F medium. Arrowheads, single cell; circled areas, colonies.
Scale bars represent 10 mm (D–G) and 50 mm (C and I).to isolate GFP and SSEA1 double-positive cells using the
gates shown in Figure 2D prior to analysis. BS-PCR analysis
of the sorted cells revealed that the Snrpn ICC is hypome-
thylated in all EGC lines, with one line (D10-7) exhibiting
some DNA methylation (18% methylated CpGs). In
contrast, the H19/Igf2 ICC was almost completely methyl-Stem Cellated in every EGC line, regardless of whether the EGC
line was male or female (Figure 3A and quantified in Fig-
ure 3B), indicating that the memory of embryo gender
(male or female) was lost with EGC derivation. This is
because, if XX EGC lines remembered their origin as
being from female embryos, they should have remainedReports j Vol. 5 j 337–349 j September 8, 2015 j ª2015 The Authors 339
Figure 2. Ex Vivo Cultured PGCs Revert to Pluripotency and Lose MVH Expression
(A) Image of GFP+ EGC colonies derived from E9.5 PGCs cultured in 7F medium.
(B) OCT4+ EGCs are negative for MVH protein as determined by immunofluorescence.
(C) Positive control using anti-MVH antibody on EGCs transfected with a transgene (t) expressing VASA.
(D) Representative flow plot for stage-specific embryonic antigen 1 (SSEA1) and GFP expression by EGCs.
(E) Quantification of SSEA1 and GFP double-positive cells in three independently derived EGC lines (n = 3 biological replicates of each).
(F) Teratoma analysis to test for pluripotency. EGCs derived from 7F-cultured PGCs were injected into three mice; 100% of mice exhibited
teratomas with evidence of endoderm (left), mesoderm (middle), and ectoderm (right) by histology.
Scale bars represent 50 mm (A) and 20 mm (B, C, and F).hypomethylated at the paternally methylated H19/Igf2
ICC after imprinting erasure.
To expand our analysis, we also evaluated sublines of
EGCs by picking individual colonies at passage 6 from a
mixed EGC line. This line (called EGC-1) was generated
by combining and sorting embryos at E9.5 prior to plating
all the pooled PGCs on a single PET membrane in 7F me-
dium. DNAmethylation in the EGC sublines was evaluated
four passages after picking EGC colonies (passage 10 total
after plating on MEFs in serum + LIF). Similar to inde-
pendently derived EGC lines (where the EGC lines were
established from individual embryos), the sublines also
were hypomethylated at the Snrpn ICC, while being
hypermethylated at the H19/Igf2 ICC (Figure 3C and
quantified in Figure 3D). We noted that one subline (K13)
had 39% CpG methylation at the Snrpn ICC, whereas the
other sublines ranged from 9%–14%, indicating some vari-
ability among lines. We also examined two additional
ICCs, the Igf2 receptor (Igf2r) and Kcnq1ot1, and discovered
that, similar to Snrpn, these ICCs were demethylated
in EGCs (Figure 3E). Taken together, we discovered that
Snrpn, Igf2r, and Kcnq1ot1 ICCs are stably hypomethylated340 Stem Cell Reports j Vol. 5 j 337–349 j September 8, 2015 j ª2015 The Ain EGC lines derived from E9.5 PGCs. In contrast, the
H19/Igf2 ICC was consistently hypermethylated regardless
of the sex of the embryo from which the PGCs were
isolated.
ICC Erasure Occurs within the First 4 Days of
Culture in 7F
To determine how these unique methylation states at the
Snrpn and H19/Igf2 ICCs are achieved, we evaluated DNA
methylation using BS-PCR every day for the first 4 days of
culture in 7F medium, and we discovered that erasure
occurred within the first 4 days at both the Snrpn and
H19/Igf2 ICCs (Figure 4A). In contrast, ESCs cultured in
7F did not erase methylation (Figure 4A).
To evaluate stability of the hypomethylated state with
further culture, we examined PGCs at day 6 and day 8 in
7F medium (Figure 4B). We discovered that the Snrpn ICC
remained hypomethylated at day 6 with an increase in
CpG methylation at day 8 (Figure 4B). Similarly, the H19/
Igf2 ICC was hypomethylated at day 6 of culture, however,
by day 8, fully methylated alleles of H19/Igf2 were identi-
fied (Figure 4B).uthors
Figure 3. EGCs Derived from E9.5 PGCs Exhibit Locus-Specific De Novo Methylation at H19/Igf2 but Not Snrpn, Igf2r, or Kcnq1ot1
ICCs
(A) Three independent EGC lines generated from GFP+ cells isolated from individual embryos. Genotype of the EGC lines is shown as female
(XX) or male (XY). Open circles, unmethylated CGs; closed circles, methylated CGs.
(B) Quantification of percentage CpG methylation levels in three EGC lines (mean and SEM).
(C) Four EGC sublines were generated from pooled GFP-positive PGCs from two litters of embryos at E9.5. Individual EGC colonies from the
parental line were picked at passage 6 and expanded to generate the sublines for BS-PCR analysis at passage 10.
(D) Quantification of percentage CpG methylation in four EGC sublines (mean and SEM).
(E) BS-PCR for Igf2r and Kcnq1ot1 ICCs in the indicated EGC lines.
Significance in (B) and (D) was calculated using a one-way ANOVA followed by Tukey’s multiple comparison test. Significance was accepted
at < 0.05.To determine whether re-methylation was associated
with changes in expression of de novo methyltransferases,
we performed real-time PCR for Dnmt3a, Dnmt3b, and
Dnmt3l using E9.5 PGCs as a control. We discovered that,
on day 4 of 7F culture, a 9-fold increase in Dnmt3l was
observed followed by an increase in Dnmt3b in the EGC
line (Figure 4C). Levels of Dnmt3a did not change. There-
fore, the increase in DNA methylation at the H19/Igf2Stem CellICC in EGCs is accompanied by an increase in the expres-
sion of the de novo methylation machinery beginning
with the derepression of Dnmt3l.
PGCs Differentiated from ESCs Share Similarities
with E9.5 PGCs and EGCs
Given that culture of E9.5 PGCs in 7Fmedium leads to sus-
tained hypomethylation of the Snrpn ICC, we reasonedReports j Vol. 5 j 337–349 j September 8, 2015 j ª2015 The Authors 341
Figure 4. Ex Vivo Culture of PGCs Results in ICC Erasure within the First 4 Days
(A) The dynamics of cytosine demethylation at the Snrpn and H19/Igf2 ICCs during a 4-day culture of E9.5 PGCs in 7F medium (n = 1
biological series with ten or more independent clones per time point). Methylation erasure was shown in two biological replicates. ESCs
cultured under the same conditions do not lose cytosine methylation at the Snrpn ICC. Open circles, unmethylated CGs; closed circles,
methylated CGs.
(B) Snrpn and H19/Igf2 ICCs are hypomethylated at day 6 and day 8 of culture (n = 1 biological series with ten or more independent clones
per time point).
(C) Real-time PCR for the de novo methyltransferases Dnmt3a, Dnmt3b, and Dnmt3l (n = 2 biological replicates each of E9.5 PGCs, day 4
PGCs cultured in 7F, and EGCs).that this could be used as an assay to evaluate Snprn ICC
erasure from PGCs differentiated in vitro from ESCs. To
test this, we used two different approaches for generating
PGCs (Figure 5A). Both methods result in the differentia-
tion of PGCs that are globally hypomethylated while still
exhibiting DNA methylation at ICCs, suggesting an iden-
tity close to E9.5–E10.5 PGCs in the embryo (Hayashi
et al., 2012; Vincent et al., 2013). For the majority of our
experiments, we used an ESC line called Blimp1-mVENUS,
Stella-CFP (BVSC), which is a double reporter ESC line in
which Blimp1 and Stella expression are reported by trans-
genes driving the expression of cell-membrane-targeted
VENUS (mVENUS) and CFP, respectively (Hayashi et al.,
2011). All germline differentiation experiments with the
BVSC ESC line were performed between passage 21 and
passage 25.
BVSC ESC lines are traditionally cultured in the naive
ground state, which is a basal medium containing an
inhibitor of glycogen synthase kinase 3 and an inhibitor
of mitogen-activated protein kinase (2 inhibitors or 2i)
plus LIF (Ying et al., 2008). ESCs cultured in 2i + LIF are342 Stem Cell Reports j Vol. 5 j 337–349 j September 8, 2015 j ª2015 The Aused to generate PGCs in a two-step protocol, with the first
step involving a 2-day differentiation into epiblast-like
cells (EpiLCs) followed by aggregation as floating culture
in the presence of cytokines. This approach generates
PGC-like cells (PGCLCs) (Hayashi et al., 2012). The second
approach involves culturing BVSC ESC lines in classic
ESC culture conditions on MEFs in medium containing
serum + LIF. From this state, the BVSC ESCs are differenti-
ated spontaneously as embryoid bodies (EBs) in hanging
drops (Vincent et al., 2013). This second approach creates
in vitro PGCs (iPGCs).
To confirm PGC identity with in vitro differentiation, we
stained EBs or aggregates for the germline marker STELLA
(also called DPPA3), and we demonstrated that BVSC-
positive cells also are positive for STELLA protein (Fig-
ure 5B). To characterize the in-vitro-differentiated germline
cells, we performed FACS to isolate the mVENUS/CFP
double-positive putative germline population (Figure 5C),
and we performed RNA sequencing (RNA-seq) to com-
pare PGCLCs, iPGCs, EGCs, and E9.5 PGCs sorted from
the Oct4-IRES-Gfp mouse. Principal component analysisuthors
Figure 5. ESC-Derived PGCs Are Transcriptionally Distinct from E9.5 PGCs and EGCs
(A) Schematic representation of the approach used to differentiate PGCs from ESCs.
(B) Phase contrast (left) and BVSC double-positive cells (right) in the EB or aggregate. BVSC double-positive cells are positive for
endogenous STELLA by immunofluorescence.
(C) FACS plot for BVSC PGCLCs or iPGCs.
(D) RNA-seq and PCA of PGCLCs (n = 2 biological replicates), iPGCs (n = 2 biological replicates), EGCs (n = 2 biological replicates), and E9.5
Oct4-Gfp-positive PGCs (n = 2 biological replicates).
(E–G) Average gene expression in fragments per kilobase of exon per million (FPKM) of selected genes in each sample shown (n = 2
biological replicates in technical duplicate).
Scale bars in (B) represent 20 mm. See also Figure S1 and Tables S1, S2, and S3.(PCA) revealed that the EB and aggregate method of ESC
differentiation generates germline cells (iPGCs or PGCLCs)
that are closely related to each other, yet are distinct from
EGCs and E9.5 PGCs from the embryo (Figure 5D; Tables
S1 and S2). Analysis of the tripartite signature for PGC
specification, namely Prdm14, Prdm1 (Blimp1), and Tfap2c,
as well as Dppa3 (Stella), revealed no difference relative
to E9.5 PGCs sorted from the embryo, consistent with a
germline identity (Figures 5E and 5F). In contrast, in-vitro-
differentiated PGCs repressed Lats2 and expressed Dnmt3l
at levels more typical of EGCs (Figure 5G), with Dnmt3b
in iPGCs and PGCLCs intermediate between E9.5 PGCsStem Celland EGCs. Furthermore,Dnmt3a andDnmtlwere expressed
in all samples, with Uhrf1 mRNA consistently higher
in iPGCs, PGCLCs, and EGCs relative to E9.5 PGCs (Fig-
ure S1A). This suggests that PGCs differentiated from
ESCs share transcriptional properties with both PGCs and
EGCs.
To evaluate the global transcriptional relationship in an
unbiased way, we performed unsupervised hierarchical
clustering of the eight RNA-seq libraries, and we found
that the transcriptome of ESC-derived PGCs, regardless of
differentiation approach, was more closely related to the
transcriptome of EGCs than to E9.5 PGCs (Figure S1B).Reports j Vol. 5 j 337–349 j September 8, 2015 j ª2015 The Authors 343
Gene ontology (GO) analysis of differentially expressed
genes among groups revealed categories including protein
transport, embryonic development, cell signaling, cell
cycle, and transcription (Figure S1C; Table S3). Notably,
E9.5 PGCs exhibited a unique enrichment of genes
involved in transcription, RNA splicing, and cell-cycle
regulation (group 8). In contrast, PGCLCs exhibited
enrichment of genes associated with protein catabolic
process and RAS signal transduction (groups 3 and 4). In
iPGCs, which were overall closely related to PGCLCs,
unique categories could still be identified. Specifically
iPGCs had elevated expression of embryonic development
genes (group 2). Taken together, our RNA-seq analysis
indicates that iPGCs and PGCLCs share a common tran-
scriptional program with E9.5 PGCs sorted from the em-
bryo. However, using unbiased clustering, we discovered
an overall closer relationship with EGCs than with E9.5
PGCs, including aberrant upregulation of RNAs involved
in de novo and maintenance DNA methylation. Given
these properties, we hypothesize that methylation reprog-
ramming in PGCs derived from ESCsmay be different from
E9.5 PGCs sorted from the embryo.
To address this, we assayedDNAmethylation at the Snprn
and H19/Igf2 ICCs in undifferentiated ESCs and germline
cells at day 6 of differentiation (Figures 6A and 6B). Our
results showed that the Snrpn ICC had on average 45%
methylation in the undifferentiated state and 49%methyl-
ation in the iPGCs and PGCLCs (Figure 6B). In contrast, we
discovered that the H19/Igf2 ICC was abnormally hyper-
methylated in undifferentiated ESCs, regardless of whether
they were cultured in 2i + LIF or serum + LIF (Figure 6A).
Given the Snrpn ICC methylation pattern was similar to
PGCs from the embryo, we next evaluated whether the
Snrpn ICC was hypomethylated in EGC lines derived
from ESC-derived PGCs. Our results showed that EGC lines
derived from PGCLCs were hypomethylated at the Snrpn
ICC (Figure 6C). In contrast EGC lines derived from iPGCs
exhibited on average 50% methylation. This suggests that
iPGCs are either not capable of erasing methylation from
the Snrpn ICC or that the erased state is not stable (Fig-
ure 6C). To address this, we examined the Snrpn ICC in
iPGCs and PGCLCs during the first 4 days of culture in 7F
medium (Figure 6D). Our results showed that the Snprn
ICC underwent demethylation within the first 4 days of
7F culture when starting from either iPGCS or PGCLCs
(Figure 6D). To confirm this result, we evaluated additional
ESC lines (called R1 and V6.5), and we isolated iPGCs at
day 6 of differentiation using the SSEA1/cKIThigh sorting
approach in Vincent et al. (2011; Figure S2). These results
showed that erasure of CpG methylation from the Snrpn
ICC is a characteristic feature of in vitro PGC differentia-
tion. However, unlike PGCs from the embryo, which
remain stably hypomethylated at this ICC, the PGCs344 Stem Cell Reports j Vol. 5 j 337–349 j September 8, 2015 j ª2015 The Adifferentiated fromESCs regained CpGmethylationwithin
24 hr of the erasure point in all cases. The reason why
the PGCLCs subsequently lose DNA methylation again at
the Snrpn ICC between 7F culture and EGC derivation is
unclear.
Starting germ cell differentiation with ESCs containing
an abnormally hypermethylated H19/Igf2 ICC leads to a
complex DNA methylation phenotype. In EGC lines
derived from iPGCs, the methylation levels remain high;
however, we noted a significant loss of methylation at
the H19 ICC in the EGC lines derived from PGCLCs (Fig-
ure 6E). Furthermore, in the first 4 days of 7F medium, no
obvious methylation erasure occurred (Figure 6F). There-
fore, the methylation loss observed in EGCs derived from
PGCLCs may correspond to erosion of the abnormally
hypermethylated state at H19/Igf2 ICC, and this also may
imply erosion of DNA methylation at the Snrpn ICC in
EGC lines derived from PGCLCs.DISCUSSION
In this study we have addressed a long-standing question
in the field regarding methylation erasure at ICCs during
reversion of PGCs to EGCs in vitro. We discovered that
initiating reprogramming fromE9.5 PGCs results in erasure
of cytosinemethylation from ICCswithin the first 4 days of
in vitro culture, therefore rejecting the notion that estab-
lished EGC lines represent the epigenetic state of PGCs
from which they were derived. Furthermore, our data
suggest that the first 4 days of PGC culture resemble the
dynamics of ICC methylation erasure normally observed
in the mouse embryo (Hackett et al., 2013; Yamaguchi
et al., 2012, 2013). Therefore, we propose that the 7F
PGC culture system is an important new model for under-
standing mechanisms of locus-specific cytosine demethy-
lation in the germline. In particular in future studies, this
model could be used to address the locus-specific removal
of cytosinemethylation downstream of oxidation (Hackett
et al., 2013; Yamaguchi et al., 2012, 2013), activation-
induced cytidine deaminase (Popp et al., 2010), or base
excision repair (Ciccarone et al., 2012; Kawasaki et al.,
2014), the outcomes of which will be important to stem
cell biology and reprogramming in general.
All PGCs differentiated from ESCs in our study, regardless
of differentiation approach or sorting strategy, were
capable of implementing ICC erasure at the Snprn ICC.
However, unlike E9.5 PGCs from the embryo, the hypome-
thylated state at this ICC was unstable, and in every case
re-methylation was initiated within 24 hr. This cannot be
explained by the natural course of germline development,
as wild-type XY germline cells in vivo never re-methylate
the Snprn ICC following erasure, and all ESC lines used inuthors
Figure 6. ESC-Derived PGCs Exhibit Unstable Imprint Erasure
(A) Snrpn and H19/Igf2 ICC methylation in undifferentiated BVSC ESCs cultured in serum + LIF on MEFs or in 2i + LIF (n = 1 biological series
with nine or more independent clones per time point).
(B) Snrpn and H19/Igf2 ICC methylation in BVSC-positive iPGCs or PGCLCs (n = 1 biological series withR12 independent clones per time
point).
(C) Average percentage CpG methylation at the Snrpn ICC in EGC lines derived from iPGCs, PGCLCs, or PGCs (n = 3–4 biological replicates per
group).
(D) Snrpn ICC methylation during the first 4 days of 7F culture starting with iPGCs or PGCLCs (n = 1 biological series with ten or more
independent clones per time point).
(E) Average percentage CpG methylation at the H19/Igf2 ICC in EGC lines derived from iPGCs, PGCLCs, or PGCs (n = 3–4 biological replicates
per group).
(F) H19/Igf2 ICC methylation during the first 4 days of 7F culture starting with iPGCs or PGCLCs (n = 1 biological series with eight or more
independent clones per time point). Open circles, unmethylated CGs; closed circles, methylated CGs.
Significance among three groups in (C) and (E) was calculated using a one-way ANOVA followed by Tukey’s multiple comparison test. Note
that the methylation percentages for EGCs derived from E9.5 PGCs in (C) and (E) are the same as those in Figure 3D. See also Figure S2.this study were XY. Our hypothesis is that germline cells
differentiated from mouse ESCs in vitro exhibit a lower
barrier to EGC reversion and this is accompanied by
abnormal expression of genes encoding proteins required
for DNA methylation. The RNA-seq analysis supports this
hypothesis given that both iPGCs and PGCLCs enter the
7F medium experiment with a transcriptional program
that is more closely related to EGCs. However, we cannot
rule out the possibility of heterogeneity in the EGC
derivation system, leading to selective growth of cellsStem Cellwith particular methylated signatures. One way to address
this in the future would be to perform single-cell methyl-
ation sequencing.
Correct erasure and removal of methylation from ICCs
in the germline needs to be seriously considered if the
entire process of PGC differentiation into gametes is to be
successfully attempted in vitro. Male and female PGCLCs
have been differentiated successfully into terminally
differentiated germ cells capable of fertilization, but only
after transplantation of the PGCLCs into a gonadal nicheReports j Vol. 5 j 337–349 j September 8, 2015 j ª2015 The Authors 345
(Hayashi et al., 2011, 2012). The differentiation of func-
tional germline cells using this approach is a remarkable
achievement and one of the few in-vitro-differentiated
cell types proven successful in functional assays. However,
not all PGCLCs are capable of differentiation within the
niche after transplantation, with many germ cells dying
for unknown reasons (Hayashi et al., 2011, 2012). Further-
more, offspring born after fertilizing PGCLC-derived male
germ cells are not always healthy, with some mice dying
prematurely with head and neck tumors (Hayashi et al.,
2011). In the case of PGCLC-derived oocytes, a high
proportion do not extrude the second polar body upon
fertilization, leading to abnormal 3-pronuclear embryos
(Hayashi et al., 2012). Therefore, there is still much to be
understood about the process of differentiating high-
quality gametes in vitro and in vivo, and our study would
suggest that methylation erasure at ICCs is one of the
vulnerable developmental transitions prone to error.
In future studies it will be important to determine
whether gonadal niche cells protect in-vitro-differentiated
germline cells from aberrant acquisition of DNA methyl-
ation and to suppress the potential for EGC reversion,
which could lead to germ cell tumors following trans-
plantation. Finally, our data highlight the importance of
initiating PGC differentiation from ESCs with a normal
epigenome. Abnormal hypermethylation of the H19/Igf2
ICC has been reported in Rhesus macaque ESC lines as
well as human ESCs (Mitalipov et al., 2007; Park et al.,
2009). Our work demonstrates that abnormal hypermethy-
lation of the H19/Igf2 ICC in undifferentiated ESCs is not
erased in the ESC-to-PGC differentiationmodel, and failure
to correctly erase methylation in the germline will pose
a significant problem to the generation of high-quality
gametes in the future.EXPERIMENTAL PROCEDURES
Animals
All animal experiments were performed following guidelines
from the Care and Use of Laboratory Animals (Animal Welfare
Assurance A3196-01). CD1 females were purchased from Charles
River Laboratories, and the Oct4-IRES-Gfp knockin mice were a
kind gift from Konrad Hochedlinger (Lengner et al., 2007). Male
SCID mice for teratoma experiments were obtained from the
University of California, Los Angeles (UCLA) Humanized Mouse
Core Laboratory.ESC Lines
The R8 Blimp1-mVENUS and Stella-CFP (BVSC) ESC line was a
kind gift from Mitinori Saitou of Kyoto University and was first
published in Hayashi et al. (2011). All experiments with the R8
BVSC ESC lines were conducted between passage 21 and passage
25. The R1 B5/EGFP (see JAX FVB.Cg-Tg [CAG-EGFP] B5Nagy/J)346 Stem Cell Reports j Vol. 5 j 337–349 j September 8, 2015 j ª2015 The AESC line was kindly provided by Luisa Iruela-Arispe at UCLA, and
this experiment was conducted at passage 22. The V6.5 ESC line
was a kind gift from Robert Blelloch at the University of California,
San Francisco, and this cell line was evaluated from passage 28 to
passage 30. All ESC lines were genotyped as XY.FACS
Time-mated embryos were collected at E9.5 in 10% FBS on ice, and
dorsal regions were dissociated with 0.05% trypsin for 5–7min at
37C. The cell suspension was resuspended in 1% BSA, strained
through a 40-mM cell strainer (BD Falcon), and 1 mg/ml DAPI was
added as the viability dye. GFP-positive PGCs were sorted using a
FacsARIA (Becton Dickinson) into DMEM high glucose supple-
mented with 30% FBS. The compensation controls included
unstained cells as well as single-color controls for GFP and DAPI.
For the majority of experiments, embryos within litters were
pooled prior to FACS and approximately 1,000–1,500 PGCs were
plated onto one PET membrane. The calculated yield of PGCs
per embryo at E9.5 was estimated to be between 150 and 250
PGCs. Some experiments were performed using PGCs sorted
from single embryos without pooling in order to separate PGCs
based on sex of the embryo. Sexing of embryos was performed
onDNA extracted fromheads using PCRwith the following primer
set: SMCX-1, 50-CCGCTGCCAAATTCTTTGG-30; and SMCY-1,
5-TGAAGCTTTTGGCTTTGAG-30. In males, two bands are present
at around 300 bp, whereas in females only one band (the upper
band) is detected.
FACS to isolate cultured cells (EGCs and ESC-differentiated
PGCs) for molecular analysis was performed on single-cell suspen-
sions in PBS containing 1% BSA; 7-AAD was used to exclude dead
cells. When needed, primary and secondary antibody incubations
were performed on ice for 10–20 min. Specifically, ScKhigh iPGCs
were stained for c-KIT (553352, BD Biosciences) and for SSEA1
(MC-480, Developmental Studies Hybridoma Bank [DSHB]) as
previously described (Vincent et al., 2013). Secondary antibodies
were anti-rat-PE for cKIT (112-116-143, Jackson ImmunoResearch)
and anti-mouse-Cy5 (115-495-044, Jackson ImmunoResearch).
Compensation controls included unstained or secondary anti-
body-only controls and single-color controls for 7AAD, PE, and
Cy5. Oct4-Ires-Gfp EGCs were stained using the anti-SSEA1
(MC-480, DSHB) antibodywith an anti-mouse IgM-Cy5 secondary
antibody (115-175-044, Jackson ImmunoResearch). Cells were
sorted based on Cy5/GFP double-positive signals. Compensation
controls included unstained and secondary antibody-only con-
trols and single-color controls for GFP and Cy5. PGCLC and
BVSC iPGCs were sorted based on mVenus and CFP fluorescence.
The compensation controls included unstained and single-color
7AAD, GFP (for Venus), and Pacific Blue (for CFP). Data were
analyzed using FlowJo software (Tree Star).PGC Culture in 7F Medium
Sorted PGCs were cultured in 7F medium, which was based on
the formulation of Farini et al. (2005) without the addition
of retinoic acid. Therefore, 7F medium contains the following:
15%FBS (Hyclone), DMEMhigh glucose (Gibco), 13non-essential
amino acids (Gibco), 0.1 mM 2-mercaptoethanol (Gibco),
0.25 mM pyruvate (Gibco 100 mM), 13 PSG (100 U/ml penicillin,uthors
100 mg/ml streptomycin, 292 mg/ml L-glutamine [Gibco]),
50 ng/ml SCF (PeproTech), 10 ng/ml bFGF (Biological Resources
Branch of the Frederick National Laboratory for Cancer Research),
10 ng/ml SDF1 (R&D Systems), 25 ng/ml human BMP4 (R&D
Systems), 500 U/ml LIF (Millipore), 5 mM forskolin (Sigma), and
1 mg/ml N-acetyl-L-cysteine (Sigma). Cells were plated directly
on 0.4-mM PET membranes (BD Falcon) in 24-well plates and
cultured at 37C with 5% CO2 with daily medium changes. For
some downstream experiments, cultured PGCs were detached
from the membrane with 0.05% trypsin for 5 min at 37C.
ESC and EGC Culture and ESC Differentiation
ESC and EGC growth in serum + LIF on MEFs and EB differen-
tiation were performed as described previously (Vincent et al.,
2011). Maintenance of BVSC ESCs in 2i + LIF on laminin followed
by EpiLC induction and PGCLC generation in aggregates were
performed as described previously (Hayashi et al., 2011).
BS Sequencing
BS treatment followed by PCR and sequencing of clones were per-
formed as described previously for Snprn (Hargan-Calvopina et al.,
2015),H19/Igf2 (Kagiwada et al., 2013), Igf2r (Lucifero et al., 2002),
and Kcnq1ot1 (Sharif et al., 2007).
RNA-Seq
Total RNA was extracted from E9.5 endogenous PGCs, iPGCs,
PGCLCs, and EGCs using QIAGEN RNeasy Micro Kit (QIAGEN)
and eluted in 8 ml of Rnase-free water. Two biological replicate
samples were used with the following start cell numbers: E9.5
PGCs (250 cells), iPGCs (1,500 cells), PGCLCs (300–500 cells),
and EGCs (two independent lines, EGC4 and EGC7, each at 500
cells). RNA was amplified and converted to cDNA using the
Ovation RNA-Seq System V2 (NuGEN). cDNA was diluted to
130 ml using TE buffer (Tris [pH 8.0] 10 mM, 15568-025 and
EDTA 0.1 mM, 15575, both from Invitrogen), transferred to
Snap-Cap MicroTUBEs with AFA fiber (520015, Covaris), and son-
icated to DNA fragments within the 200-bp range using a Covaris
S2 sonicator according to the manufacturer’s instructions (duty
cycle 10%, intensity 5, cycles per burst 200, and time 180 s). Sub-
sequently, libraries were generated using the Encore Rapid Library
System according to the manufacturer’s instructions. Library
concentration was estimated using a Kapa library quantification
kit (4827) according to the manufacturer’s instructions on a ViiA
7 Real-time PCR System (Invitrogen). Libraries were run using
50-bp single-end reads on the HiSeq 2500 System (Illumina). Eight
libraries were multiplexed and run in two lanes. ERCC RNA Spike-
In Mix (4456740, Invitrogen) was used according to the manufac-
turer’s instructions.
RNA-Seq Data Analysis
Reads with low quality and reads containing sequencing adapters
were first filtered out before mapping raw reads (single end,
50 bp in length) to the Mus musculus reference genome
(GRCm38/mm10) with the gapped aligner Tophat 2 (Kim et al.,
2013), allowing up to two mismatches. Only uniquely aligned
reads were collected. In total for all libraries sequenced, on average
13.9 million reads for each sample were mapped uniquely (corre-Stem Cellsponding to an overall mappability of 70%) and used for further
analysis.
External RNA Controls Consortium (ERCC) standards were
calculated to have an average observed and expected correlation
of R = 0.93. Transcript expression levels were quantified in FPKM
(fragments per kilobase of exon per million reads mapped) units
using Cufflinks (version 2.2.1). The FPKM values of repeats were
calculated according to coding transcripts. We filtered out genes
with FPKM < 0.5 in all groups. The multiple testing errors were
corrected by the false discovery rate (FDR). In addition to the
FDR of < 0.05, we considered differentially expressed genes as
having >2-fold difference. The heatmap in Figure S1 was generated
(p% 0.01, FDR < 0.05, fold change > 2) using the default settings
with the function ‘‘heatmap.2’’ in the gplots package of R. FPKM
values are centered and scaled by subtracting the mean of the
row from every FPKM value and then dividing the resulting
FPKM values by the SD of the row.
Unsupervised hierarchical clustering was performed to examine
the correlation and linkage of samples using R. In the process of
clustering, we employed ‘‘complete’’ as the agglomerationmethod
and the Pearson product-moment correlation coefficient as the
distance metric. The PCA was performed on normalized read
counts of all samples to compare gene expression under different
developmental stages using the ‘‘princomp’’ function in R. In
this analysis, we selected 1,000 top-ranked genes based on their
variations across all samples using the function ‘‘rowVars’’ in R
matrixStats package. PCA revealed that our samples were clearly
distinguishable by both the first, second, and third principal
component. GO term analysis was performed with the Database
for Annotation, Visualization, and Integrated Discovery (DAVID)
(Huang da et al., 2009).
Immunofluorescence and Microscopy
Unless otherwise indicated, 4% paraformaldehyde (PFA) in PBS
was used as a fixative, 10% FBS/0.05% Tween20 was used as a
blocking agent, and 0.2% Tween20 was used for washing. Pri-
mary antibody incubations were carried out overnight at 4C.
Secondary antibody incubations were for 1 hr at room temper-
ature. After washing, samples were imaged in Prolong Antifade
Reagent with DAPI (Invitrogen). For E9.5 embryos and adult
testes, whole-mount immunofluorescence was performed after
fixing in 4% PFA. Primary antibodies were incubated overnight
at 4C using anti-OCT4 (1:100; sc8628, Santa Cruz Biotech-
nology) and anti-mouse VASA homolog (1:100; ab13840, Ab-
cam); secondary antibodies also were stained in block solution
overnight at 4C. For MVH staining of cultured E9.5 PGCs, cells
were harvested from the membrane and attached to a poly-L-
lysine-coated coverslips before fixing for 15 min in 4% PFA at
room temperature. Permeabilization was performed with 0.5%
Triton X-100, followed by an overnight incubation in anti-
MVH (1:100; ab13840, Abcam) or rabbit IgG. For iPGC and
PGCLC aggregates, whole-mount immunofluorescence was per-
formed after fixing in 4% PFA followed by permeabilizing in
1% Triton X-100 in PBS plus 2 mg/ml Collagenase type IV. Pri-
mary antibody anti-STELLA (1:100) (sc67249, Santa Cruz) was
incubated overnight at 4C and secondary antibody Cy5 anti-
rabbit (1:200) was stained in 0.3% Triton X-100 in PBS for
2 hr at room temperature. All cells and aggregates were imagedReports j Vol. 5 j 337–349 j September 8, 2015 j ª2015 The Authors 347
with an LSM 780 confocal microscope (Zeiss) using ZEN 2011
software.
Teratoma Assays
Teratomas were generated in the testis as previously described
(Conway et al., 2009; Lindgren et al., 2011). Briefly, SCID mice
were injectedwith 13 106 EGCs re-suspended in 50 ml BDMatrigel
(BD Biosciences) per testis. The testes were removed 4 weeks later,
processed in paraffin for sectioning, and stained with H&E for
histological analysis.
Real-Time PCR
PGCs and iPGCs were sorted into RLT buffer (QIAGEN) and their
RNA isolated using the RNeasy Micro Kit (QIAGEN). EGCs were
sorted using SSEA1/GFP prior to RNA isolation. Reverse transcrip-
tion was performed with Superscript RT II (Invitrogen) and the
following Taqman gene expression assays were used for real-time
PCR: Dnmt3a, Dnmt3b, and Dnmt3l. Ct values were normalized
to Gapdh and expressed as a fold change relative to E9.5 PGC.
Statistics
For comparisons among three groups, one-way ANOVA was per-
formed followed by Tukey’s multiple comparison test. Significance
was accepted at p < 0.05. All error bars shown are mean and SEM.
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